International consensus on dose reduction of biologics for patients with psoriasis: The DR . Delphi study

Documenti analoghi

• Bridging theory and practice in model‐informed precision dosing of medication in inflammatory skin diseases
  di: J. M. P. A. van den Reek, et al.
  Pubblicazione: (2026)
• The lifestyle of psoriasis patients and their motivation to change
  di: M. Al‐Gawahiri, et al.
  Pubblicazione: (2024)
• Unveiling the impact of itch, pain, fatigue and disease severity in paediatric patients with psoriasis and the influence of methotrexate and biologics
  di: S. E. Thomas, et al.
  Pubblicazione: (2024)
• International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study
  di: Anouk G. M. Caron, et al.
  Pubblicazione: (2024)
• Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus
  di: T. Torres, et al.
  Pubblicazione: (2024)